Stem, Inc. (STEM)
$
24.59
+0.93 (3.78%)
Key metrics
Financial statements
Free cash flow per share
-5.0314
Market cap
249 Million
Price to sales ratio
1.5962
Debt to equity
-1.5062
Current ratio
0.8855
Income quality
1.6838
Average inventory
6.7 Million
ROE
0.0638
Technology
Technology – consumer electronics
Largecap
With a market cap of 121,78 bil stock is ranked 1
Low risk
ISS score of this stock is ranked 1
Company description
Profile
Stem, Inc. operates as a digitally connected and intelligent energy storage network provider in the United States and internationally. The EBITDA is -$790,401,000.00 a key indicator of the company's operational profitability. The cost of revenue for the company is $155,642,000.00 showcasing its production and operational expenses. Despite its advanced solutions, the company reported a net loss of -$854,014,000.00 indicating challenges in its operations. Furthermore, the earnings per share (EPS) is reported at -$105.80 indicating the company's profitability on a per-share basis. The income before tax ratio is -$5.90 reflecting the pre-tax margin. Stem, Inc. provides energy storage systems sourced from original equipment manufacturers (OEMs) and offers its innovative Athena artificial intelligence platform, which delivers battery hardware and software-enabled services for optimal operation of energy storage systems. Additional services include system design and engineering, supply chain management, energy storage value stream optimization, and program enrollment and incentive management services. The company caters to commercial and industrial enterprises, independent power producers, renewable project developers, as well as utilities and grid operators, and it was incorporated in 2009 with headquarters in San Francisco, California. The stock is affordable at $18.10 suitable for budget-conscious investors. It also boasts a high average trading volume of 435,706.00 indicating strong liquidity. With a market capitalization of $205,538,122.00 the company is classified as a small-cap player. Stem, Inc. is a key player in the Software - Infrastructure industry, contributing significantly to the overall market landscape. Additionally, it belongs to the Technology sector, driving innovation and growth. Overall, Stem, Inc. combines cutting-edge technology with proactive management to enhance energy storage solutions while navigating the complexities of the market effectively.
Investing in Stem, Inc. (STEM) depends on multiple factors, including revenue growth, profit margins, debt-to-equity ratio, earnings per share, and return on equity. Analysts have rated it as C-, with a Bearish outlook. Always conduct your own research before investing.
Analysts predict Stem, Inc. stock to fluctuate between $5.82 (low) and $33.60 (high) in the next 365 days, reflecting market expectations and potential volatility.
As of 2025-10-20, Stem, Inc.'s market cap is $205,538,122, based on 8,358,606 outstanding shares.
Compared to Meta Platforms, Inc. Class A Common Stock, Stem, Inc. has a Lower Market-Cap, indicating a difference in performance.
To buy Stem, Inc. (STEM) stock: Open a brokerage account (e.g., Robinhood, TD Ameritrade, E-Trade). Search for STEM. Place an order (Market, Limit, etc.).
The best time to invest depends on market trends and technical indicators, which show a Bearish trend based on economic conditions and company performance.
Stem, Inc.'s last stock split was 1:20 on 2025-06-23.
Revenue: $144,584,000 | EPS: -$105.80 | Growth: 486.14%.
Visit https://www.stem.com/investor-relations for detailed financial reports.
You can explore historical data from here
All-time high: $32.23 (2025-10-15) | All-time low: $0.29 (2025-04-16).
Key trends include market demand, economic conditions, interest rates, and industry competition, which influence the stock's performance.
News
globenewswire.com
SOUTH SAN FRANCISCO, Calif., Oct. 15, 2025 (GLOBE NEWSWIRE) -- CERo Therapeutics Holdings, Inc. (Nasdaq: CERO) (“CERo” or the “Company”), an innovative cellular immunotherapy company, announces that Chris Ehrlich, Chief Executive Officer will participate in a stem cell therapy panel titled, “A Space That is Ready to Have its Day,” at the Maxim Growth Summit presented by Maxim Group LLC. The Summit is being held on October 22 – 23, 2025 at the Hard Rock Hotel in New York City.
businesswire.com
BERLIN--(BUSINESS WIRE)--Stem, Inc. (NYSE: STEM), a global leader reimagining technology to support the energy transition, today announced the expansion of its Berlin operations with a move to centralized and collaborative facilities. The new office underscores Stem's commitment to advancing utility-scale solar, storage and hybrid solar-plus-storage projects across the EMEA region. The enhanced 400-square-meter space nearly doubles workspace capacity, bringing Stem's engineering, sales, and cus.
businesswire.com
HOUSTON--(BUSINESS WIRE)--Stem (NYSE: STEM), a global leader in AI-enabled clean energy software and services, will hold a conference call on Wed., Oct. 29, 2025, to discuss its results for the quarter ended Sept. 30, 2025. The conference call is scheduled to begin at 5:00 p.m. Eastern Time. A press release regarding the results will be issued at approximately 4:05 p.m. Eastern Time. The conference call may be accessed via a live webcast on a listen-only basis at https://investors.stem.com/even.
globenewswire.com
HOUSTON, Sept. 12, 2025 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) (“FibroBiologics”), a clinical-stage biotechnology company with 270+ patents issued and pending with a focus on the development of therapeutics and potential cures for chronic diseases using fibroblasts and fibroblast-derived materials, today announced the publication of an opinion editorial authored by company leadership that presents the scientific case for fibroblast cells' therapeutic advantages compared to stem cell therapies.
businesswire.com
HOUSTON--(BUSINESS WIRE)--Stem, Inc. (NYSE: STEM): Sept. 9, 2025 Dear Stem Shareholders, It has been 12 months since we announced our strategic realignment, and I want to take the opportunity to reflect on the strides we have made in transforming our business. This year has marked a journey in strategic change and realignment, and we are well on our way to success. Our progress is reflected in our latest quarterly earnings results, including driving our software and services offerings and posit.
newsfilecorp.com
Toronto, Ontario--(Newsfile Corp. - Le 3 septembre/September 2025) - The common shares of Stem Holdings Inc. will be delisted from the CSE at market close today, September 3, 2025. Stem Holdings Inc. is currently suspended.
seekingalpha.com
Stem, Inc. (NYSE:STEM ) Q2 2025 Earnings Conference Call August 7, 2025 5:00 PM ET Company Participants Arun Narayanan - Chief Executive Officer Brian Musfeldt - Chief Financial Officer Erin Reed - Corporate Participant Conference Call Participants Justin Lars Clare - ROTH Capital Partners, LLC, Research Division Operator Greetings, and welcome to the Stem Inc. Second Quarter 2025 Results Conference Call. [Operator Instructions] Please note, this conference is being recorded.
zacks.com
Stem, Inc. (STEM) came out with a quarterly loss of $3.73 per share versus the Zacks Consensus Estimate of a loss of $3. This compares to a loss of $4.4 per share a year ago.
zacks.com
STEM gears up for Q2 earnings as software momentum, cost cuts, and margin shifts drive performance trends.
businesswire.com
HOUSTON--(BUSINESS WIRE)--Stem (NYSE: STEM), a global leader in AI-enabled clean energy software and services, today announced the successful deployment of its advanced energy system at the Camino Solar project in Kern County, California, developed by Avangrid, a leading energy company and member of the Iberdrola group. Stem's expert engineering services and software platform enabled grid integration and operational excellence for this milestone renewable energy facility, delivering optimized c.
See all news